Article: New COMBIVENT(R) Inhalation Aerosol Combines Two Bronchodilators for the Treatment of Chronic Bronchitis, Emphysema

Offers More Convenient Relief of Symptoms with Potential for Cost Savings

RIDGEFIELD, Conn., June 16 /PRNewswire/ -- COMBIVENT(R) (ipratropium bromide and albuterol sulfate) Inhalation Aerosol, a preparation that combines two widely prescribed medicines in a single, convenient metered dose inhaler is now available to treat chronic obstructive pulmonary disease (COPD), known collectively as chronic bronchitis and emphysema. COMBIVENT Inhalation Aerosol is indicated for use in patients with COPD on a regular aerosol bronchodilator who continue to have evidence of bronchospasm (spasmodic airway muscle contraction) and who require a second bronchodilator to widen, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!